Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma

Kim Margolin, Michael Atkins, Joseph Sparano, Jeffrey Sosman, Geoffrey Weiss, Michael Lotze, James Doroshow, James Mier, Kevin O'Boyle, Richard Fisher, Elizabeth Campbell, Joshua Rubin, David Federighi, Stuart Bursten

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences